NCT06112639 (DANCEREX-DTx) is a NA clinical trial of DANCEREX-DTx in Sclerosis, Multiple, sponsored by Fondazione Don Carlo Gnocchi Onlus.

Who is sponsoring NCT06112639?

NCT06112639 is sponsored by Fondazione Don Carlo Gnocchi Onlus.

What drugs are being tested in NCT06112639?

Interventions in NCT06112639: DANCEREX-DTx, Multidimensional dance-based program, Educational Program.

What condition does NCT06112639 study?

NCT06112639 studies Sclerosis, Multiple, Neurocognitive Impairment, Mild, Neurocognitive Dysfunction.

Is NCT06112639 still recruiting?

NCT06112639 is currently recruiting now. Last updated 10 January 2025.

Last reviewed 2025-01-10 · How we verify

NCT06112639: DANCEREX-DTx

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The DANCEREX Proof-of-Concept Study for Chronic Neurological Disorders

Recruiting now NA Last updated 10 January 2025

What this trial tests

NA trial testing DANCEREX-DTx in Sclerosis, Multiple in 192 participants. Currently enrolling.

Timeline

31 January 2024

Primary endpoint
1 May 2025

31 October 2025

Quick facts

Lead sponsor	Fondazione Don Carlo Gnocchi Onlus
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	192
Start date	31 January 2024
Primary completion	1 May 2025
Estimated completion	31 October 2025
Sites	3 locations across Italy

Drugs / interventions tested

DANCEREX-DTx
Multidimensional dance-based program
Educational Program

Conditions studied

Sclerosis, Multiple — all drugs for Sclerosis, Multiple →
Neurocognitive Impairment, Mild — all drugs for Neurocognitive Impairment, Mild →
Neurocognitive Dysfunction — all drugs for Neurocognitive Dysfunction →

Sponsor

Fondazione Don Carlo Gnocchi Onlus — full company profile →

Who can join

Adults 18 to 85, any sex, with Sclerosis, Multiple or Neurocognitive Impairment, Mild. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to test a new digital therapeutic solution which combines a holistic, multidimensional rehabilitation program based on dance and music with an innovative motivational system (DANCEREX-DTx) in Chronic Neurological Disorders (Multiple Sclerosis and pre-Mild Cognitive Impairment - MCI/ MCI at risk of Alzheimer's Disease). The main questions it aims to answer are 1\] efficacy of the digital therapeutic solution in terms of adherence, clinical/functional measures, quality of life and surrogate measures; 2\] usability and acceptability of the system. Participants will be randomized (with an allocation ratio of 2:2:1) into the experimental group (DANCEREX - 24 sessions of multidimensional dance-based program integrated with an innovative motivational system), active comparator group (24 sessions of multidimensional dance-based program) and placebo group (24 sessions of educational program). Researchers will compare the experimental group to the other two groups to see if a digital therapeutic solution integrating a multidimensional dance-based program and motivational system is effective in increasing adherence to rehabilitation treatment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

DANCE Rehabilitation EXperience (DANCEREX-DTx): Protocol for a randomized controlled trial on effectiveness of digital therapeutics in chronic neurological disabilities.
Borgnis F, Blasi V, Realdon O, Mantovani F, et al · · 2025 · PMID 40144043 · DOI 10.1177/20552076251324448

Verify or expand the search:

Other recruiting trials for Sclerosis, Multiple

Currently open trials in the same condition.

NCT06428201 — The Efficacy of Tele Rehabilitation- Based Task-Specific Training for Cognitive Function Improvement · NA · active not recruiting
NCT05857280 — EXOPULSE Mollii Suit, Motor Function & Multiple Sclerosis (EXOSEP 2) · NA · recruiting
NCT03900221 — French Registry for Monitoring Pregnancies for Multiple Sclerosis · recruiting
NCT03600779 — Application of ihMT MRI in Multiple Sclerosis · NA · recruiting

Other Fondazione Don Carlo Gnocchi Onlus trials

Trials by the same sponsor.

NCT07252856 — Transcultural Digital Solutions in Phase III Cardiac Rehabilitation · NA · not yet recruiting
NCT07290218 — Tridimensional Robotic Assessment of Neglect in Brain Injured Patients · not yet recruiting
NCT07064226 — Validation of a Digital Intervention to Rehabilitate Cognitive Resources · NA · recruiting
NCT07130929 — Functional Electrical Stimulation to Treat Critical Neuromyopathy After Severe Stroke: a Pilot Study. · NA · recruiting
NCT07159854 — Telerehabilitation in Central and Peripheral Neurological Sequelae From Chemotherapy · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06112639 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fondazione Don Carlo Gnocchi Onlus
Last refreshed: 10 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06112639.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing